key: cord-0856247-gb9rkv9c
authors: Ejima, Keisuke; Kim, Kwang Su; Ito, Yusuke; Iwanami, Shoya; Ohashi, Hirofumi; Koizumi, Yoshiki; Watashi, Koichi; Bento, Ana I; Aihara, Kazuyuki; Iwami, Shingo
title: Inferring Timing of Infection Using Within-host SARS-CoV-2 Infection Dynamics Model: Are "Imported Cases" Truly Imported?
date: 2020-03-31
journal: nan
DOI: 10.1101/2020.03.30.20040519
sha: 6080016ea787cbc71c646fd54126fb2f36e3aa41
doc_id: 856247
cord_uid: gb9rkv9c

Importance: Although the COVID-19 epidemic in some countries such as China are in the last phase by large effort for containment of the disease, another outbreaks can occur because huge susceptible population remains. Further, there remain countries in the early phase of outbreak with zero or limited number of cases in southern hemisphere countries. In those countries at risk of future outbreak, ascertaining whether cases are imported or the result of local secondary transmission is important for government to shape appropriate public health strategies. Objective: To develop a method to estimate timing of infection establishment, which helps differentiate imported and autochthonous cases. Design, Setting and Participants: Of the first 18 cases reported in Singapore, 12 were used in our study (1 case with insufficient data and 5 on anti-viral treatment were excluded from the analysis). The viral load data from these initial cases considered imported due to their travel history to Wuhan were analyzed. Another viral load data from 3 cases reported from Zhuhai, China, for whom exposed day were known, were also analyzed to determine the viral load threshold for infection establishment. Exposures: SARS-CoV-2 infection confirmed by the polymerase-chain-reaction (PCR) test. Main Outcomes and Measures: The timing of infection establishment of each case was assessed by analysing viral load data after symptom onset using a within-host viral dynamics model for SARS-CoV-2. Estimated timing of infection will indicate whether cases are imported or autochthonous transmission within Singapore. Results: Six among the 12 cases were clearly imported cases, whereas we could not rule out the possibility of secondary transmission for the rest of 6 cases, which collectively evidenced ongoing transmission in Singapore. For the 6 cases who could be the results of secondary transmission, further investigation to identify the source of infection within Singapore should be warranted (i.e., contact tracing). Conclusions and Relevance: In an early phase of outbreak due to entrance or re-entrance of the virus to countries/communities, collecting viral load data over time from cases from symptom onset is highly recommended, because viral load data are valuable to infer the timing of infection and distinguish between imported cases and ongoing local transmission.

To avoid future outbreaks, governments implement various border control programs: 48 quarantine and isolation of confirmed and suspicious cases, and travel restriction to and from 49 countries with ongoing outbreaks. Additionally, effort focuses on identification and isolation of 50 suspicious cases. Suspicious cases that are confirmed, are followed by further investigation -51 through interviews, contact tracing, and genomic analysis -to infer whether they are imported 52 cases or secondary cases 3 . Secondary cases indicate possible local ongoing transmissions. Thus, 53 a shift in intervention programs to mitigating the burden of outbreak (e.g., school closure) is 54

Identification and differentiation of secondary transmission from imported cases is essential. 56

Traditionally, this requires interview-based assessments, which are unreliable (e.g., recall bias 57 especially when individuals travel frequently). In this study, we propose to use viral load data 58 coupled with a model to differentiate secondary transmission from imported cases. Our flexible 59 method is applicable for any countries/communities at risk of future outbreaks. 60

To illustrate this, we analyzed cases reports from Singapore. In Singapore, the first case 61 was identified on 23 rd January 2020, and currently 345 cases have been confirmed positive using 62 reverse-transcriptase-polymerase-chain-reaction (RT-PCR) test as of 19 March 2020 4 ( Figure 1A) . 63

The first 18 cases reported had travel history connecting them to Wuhan, China, thus considered 64 imported cases. Two days after the 18 th case was confirmed (3 rd February 2020), a new confirmed 65 case had not traveled to China. To investigate the possibility of some of the original 18 being 66 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

Expected day of infection establishment 72 Figure 1A depicts the weekly epidemic curve in Singapore from January 21 st to March 15 th 73 based on symptom onset and laboratory confirmation. Because the laboratory test is performed 74 after symptom onset, the epidemic curve based on laboratory confirmation follows the curve based 75 on symptom onset. For the first few weeks, the epidemic in Singapore was not in the phase of 76 exponential growth, which suggests secondary transmissions are limited and any long chains of 77 transmission did not succeed yet. The first 18 cases discussed here are in the first two weeks of 78 the epidemic. Here we assessed whether the 12 initial 'imported' cases were in fact imported or the result 90 of ongoing transmission in Singapore. We found that 6 of 12 cases were clearly infected before 91 arrival to Singapore, the other however have likely been infected after the arrival to Singapore. 92

This provides evidence of within-country transmission prior to the 19 th case being reported (3 Feb). 93 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 31, 2020. . https://doi.org/10.1101/2020.03.30.20040519 doi: medRxiv preprint autochthonous (i.e., before or after arrival to the country). The advantage of using this method is 95 that computation is solely based on viral load data. Collecting viral load in early phase of outbreak 96 is ideal for the beginning of an outbreak. We suggest this method as a complementary test to the 97 basic clinical routine for the novel disease identification. Given that recall bias is an issue, our 98 method reliably assesses the timing of infection. This estimation will be further enhanced if 99 combined with the complementary information (e.g., travel and contact history and genetic 100 information) thus reducing uncertainty in our predictions. 101

There are limitations to our approach. Our approach requires viral load data over multiple 102 time points; therefore, we may not be able to estimate the timing of infection immediately after 103 symptom onset. Further, we need to note that both the boundaries and the day of infection 104 establishment estimated using our approach could be underestimated, because infection is 105

established after exposure starts. 106

For countries and communities at risk of future COVID-19 outbreak, which include second 107 outbreaks after significant decreased transmission (i.e. China), we strongly recommend monitoring 108 the viral load in the early phase of outbreaks. As such, the method we used may be critical to help 109 shape a country's early response to an outbreak.

Materials and Methods

We obtained two datasets from two published papers 5,6 (we have not collected original data in this 114 study). Nasopharyngeal swabs were collected for the 18 cases reported in Singapore, for up to 30 115 days from symptom onset. Viral loads were measured by RT-PCR 5 . We excluded 5 cases who 116 received lopinavir-ritonavir and 1 case whose viral load was detected only twice. In total, we 117

analyzed the first 12 cases. In addition, to find "infection establishment boundary" (see Viral load 118 boundary for infection establishment) and achieve robust parameter estimation, we obtained 119 an additional dataset of viral loads measured in nasal swab collected from the 8 cases reported in 120 All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in limit were assumed to be at the detection limit for the purposes of fitting the model (see later for 125 detail). We used the program datathief III (version 1.5, Bas Tummers, www.datathief.org) to 126 extract the data from images in those publications. Waiver of informed consent was granted by 127 public health authorities or written informed consent was obtained from study participants as 128 described in the original studies. respectively. The parameters , , and represent the rate constant for virus infection, the 136 maximum rate constant for viral replication and the death rate of infected cells, respectively. All 137 viral load data including Singapore and Zhuhai patients were simultaneously fitted using a 138 nonlinear mixed-effect modelling approach, which uses samples to estimate population 139 parameters while accounting for inter-individual variation (Table 1) . Further, sampled parameter 140 sets were used to predict the estimated day of SARS-CoV-2 infection establishment, that is, the 141 start of the exponential growth phase of viral loads 9 . The infection establishment time, inf , was 142 estimated by hindcasting, when the viral load reaches the boundary. The viral load boundary for 143

infection establishment was computed using the three secondary infection cases reported in 144

Zhuhai, whose start days of exposure to the primary cases are known 6 . We assumed that the start 145 day of exposure is equal to the day of infection establishment. If the estimated day of infection is 146

All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in obtained the viral load on the start day of exposure, which is defined as the infection establishment 159

boundary: 10 −6.67 to 10 −5.18 , 10 −5.20 to 10 −3.88 and 10 −1.14 to 10 0.03 for Patients D, H and L, 160

respectively. We used the lowest (10 -6.67 ) and highest (10 0.03 ) values as the boundary. nonlinear mixed-effects model, was employed to fit the model to the viral load data. Nonlinear 165 mixed-effects modelling approaches incorporate a fixed effect as well as a random effect 166 describing the inter-patient variability in parameters. Including a random effect amounts to a partial 167 pooling of the data between individuals to improve estimates of the parameters applicable across 168 the population of cases.

All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in and Technology (to S.I.). 192

All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 199 All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

WHO Director-General's opening remarks at the media briefing on COVID-19 -11

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering

International encyclopedia of public health

Epidemiologic Features and Clinical Course of Patients 208 Infected With SARS-CoV-2 in Singapore

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of 210 Infected Patients

Detection of SARS coronavirus in patients with severe acute 212 respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. 213 Clinical chemistry

Quantifying the effect of Vpu on the promotion of HIV-1 215 replication in the humanized mouse model